Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genes2Me
Gurugram, Haryana, Indiagenes2me.com ↗
- Ownership
- Private
- Employees
- ~118
- Development stage
- Other
01
Overview
Genes2Me is a leading Indian molecular diagnostics and in vitro diagnostics (IVD) company established in 2016. Headquartered in Gurugram, India, the company develops, manufactures, and distributes advanced diagnostic technologies, including Next Generation Sequencing (NGS) clinical assays, real-time PCR kits, point-of-care (POC) testing platforms, and nucleic acid extraction systems. Genes2Me serves a global market across more than 60 countries, offering CE-IVD marked solutions that cover oncology, infectious diseases, prenatal and postnatal screening, and rare genetic disorders. Under the leadership of founder and CEO Neeraj Gupta, the company has established itself as a key player in precision medicine and accessible healthcare diagnostics.
- Industry
- Molecular Diagnostics
02
Partnerships
Imperial Life Sciences
Beyond the preview
Go deeper on Genes2Me.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genes2Me.